DataMeds AI (MEDS) Receivables - Other (2023 - 2026)

DataMeds AI (MEDS) has reported Receivables - Other for 4 consecutive years, with $4200.0 the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Receivables - Other fell 99.63% year-over-year to $4200.0; the trailing twelve-month figure through Mar 2026 stood at $4200.0 (down 99.63% YoY), and the FY2025 full-year result was $492117.0, down 51.8% from the prior year.
• Receivables - Other fell to $4200.0 in Q1 2026 per MEDS's latest filing, from $492117.0 in the prior quarter.
• Across five years, Receivables - Other topped out at $1.2 million in Q2 2025 and bottomed at $4200.0 in Q1 2026.
• Historically, Receivables - Other has averaged $676331.7 across 4 years, with a median of $492117.0 in 2025.
• The sharpest annual moves came in 2024 and 2026: Receivables - Other surged 202.97% in 2024, then slumped 99.63% in 2026.
• Over 4 years, Receivables - Other stood at $337000.0 in 2023, then soared by 202.97% to $1.0 million in 2024, then slumped by 51.8% to $492117.0 in 2025, then tumbled by 99.15% to $4200.0 in 2026.
• According to Business Quant data, Receivables - Other over the past three periods registered $4200.0, $492117.0, and $492117.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.